You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
博雅生物(300294.SZ):擬公開掛牌轉讓江西博雅欣和製藥有限公司80%股權
格隆匯 04-13 15:58

格隆匯4月13日丨博雅生物(300294.SZ)公佈,爲聚焦血液製品主業,優化公司資源配置,提升公司資本回報水平,公司於2025年4月11日召開第八屆董事會第十次會議,審議通過了《關於擬公開掛牌轉讓江西博雅欣和製藥有限公司80%股權的議案》,同意公司擬通過上海聯合產權交易所掛牌轉讓江西博雅欣和製藥有限公司80%股權,80%股權首次掛牌金額爲21,304.37萬元(以經國有資產監督管理機構授權單位備案的評估價值爲準)。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account